“…Another issue that can affect clinical success is the nature of the dose response in and adjacent to the therapeutic zone (58,60). Over the past decade considerable advances have been made in the understanding of the nature of the dose response, especially in the low-dose zone (88,116,204,280,291,292,398). These findings challenge previous concepts of the dose response, suggesting that the commonly accepted threshold and linear doseresponse models upon which society has based its toxicological and pharmacological predications for drug and chemical effects often fail to provide reliable estimates of responses in the low-dose zone, that is, below the threshold (55, 61, 69-71, 90, 91).…”